SXTC icon

China SXT Pharmaceuticals

5 hedge funds and large institutions have $66K invested in China SXT Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Millennium Management
1
Millennium Management
New York
$35K 45,685 +45,685 New
Renaissance Technologies
2
Renaissance Technologies
New York
$17K 21,572 -7,900 -27%
HF
3
HRT Financial
New York
$8K 10,870 +10,870 New
UBS Group
4
UBS Group
Switzerland
$6K 7,725 +7,725 New
VF
5
Virtu Financial
New York
-14,868 Closed
TIM
6
Tevis Investment Management
Texas
-13 Closed
CFGS
7
Concourse Financial Group Securities
Alabama
HI
8
Hudock Inc
Pennsylvania
$0 300 +150 +100%